Biozen Clinches People's Choice Award at ACC 2026 for Groundbreaking Blood Pressure Technology Biozen, LLC was honored with the 2026 People’s Choice Award at the ACC Innovation Pitch Challenge for their innovative cuffless blood pressure technology.

Biozen Clinches People's Choice Award at ACC 2026 for Groundbreaking Blood Pressure Technology #USA #Oklahoma_City #blood_pressure #Biozen #ACC_2026

Emboline's Game-Changing PROTECT H2H Trial Results Herald New Era in TAVR Embolic Protection Emboline, Inc. has unveiled groundbreaking results from its PROTECT H2H trial, showcasing the Emboliner® system's potential in TAVR procedures. This innovative approach promises to redefine embolic protection standards in cardiac interventions.

Emboline's Game-Changing PROTECT H2H Trial Results Herald New Era in TAVR Embolic Protection #USA #TAVR #Santa_Cruz #Emboliner #ACC_2026

Emboline's PROTECT H2H Trial Showcases Significant Advances in TAVR Embolic Protection Device Discover the groundbreaking results of Emboline's PROTECT H2H trial, presenting Emboliner® as a game-changer in TAVR procedures during ACC 2026.

Emboline's PROTECT H2H Trial Showcases Significant Advances in TAVR Embolic Protection Device #USA #TAVR #Santa_Cruz #Emboliner #ACC_2026

Biozen Recognized as Finalist for the ACC 2026 Innovation Pitch Challenge Biozen, LLC has been chosen as a finalist in the ACC Future Hub Innovation Pitch Challenge, showcasing cutting-edge technology in cardiovascular care.

Biozen Recognized as Finalist for the ACC 2026 Innovation Pitch Challenge #USA #Oklahoma_City #blood_pressure #Biozen #ACC_2026